Dapagliflozin 10 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VN4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,367
Award facts
- Contract value 100% obligated
- $20,366.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,366.64 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Dapagliflozin 10 mg tablets (30-count units), with a completion deadline of February 2, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for pharmaceutical and medical supply delivery to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive portfolio of medications and medical commodities to federal agencies, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive track record of federal procurement includes diverse pharmaceutical products across multiple therapeutic domains, with contract values ranging from under $100 to over $45,000. This delivery order for Dapagliflozin, a diabetes management medication, reflects the company's ongoing role in supporting military and federal healthcare operations through its established relationship with DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F7VN4?
SPE2DR26F7VN4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F7VN4 worth?
The government has obligated $20,367 on SPE2DR26F7VN4.
Is contract SPE2DR26F7VN4 an order under another contract?
Yes. SPE2DR26F7VN4 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VN4 competed?
The extent of competition for SPE2DR26F7VN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award